Mark A. Wiley, MD, FACC, FSCAI

Assistant Professor of Medicine - Cardiology
Medical School, University of Kansas School of Medicine, Kansas City KS
Internship, University of Kansas Medical Center, Kansas City KS
Residency, University of Kansas Medical Center, Kansas City KS
Fellowship, University of Kansas Medical Center, Kansas City KS (Cardiology, Interventional Cardiology)


Clinical Interests

  • Diagnostic Catheterization
  • Cardiovascular Research
  • Peripheral Artery Disease
  • Peripheral Vascular Intervention
  • Interventional Cardiology

Research Projects

Active projects

  • SPIRIT IV Clinical Trial: A Clinical Evaluation of the XIENCE VTM Everolimus Eluting Coronary Stent System in the Treatment of Subjects with de novo Native Coronary Artery Lesions. Sponsored by Abbott Vascular Devices.
  • XIENCETM V Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study. Sponsored by Abbott Vascular Devices.
  • SPIRIT PRIME Clinical Trial: A Clinical Evaluation of the XIENCE PRIME TM and XIENCE PRIME TM LL Everolimus Eluting Coronary Stent System. Sponsored by Abbott Vascular Devices.

Selected Publications

  • Pillarisetti J, Patel P, Duthuluru S, Roberts J, Chen W, Genton R, Wiley M, Candipan R, Tadros P, Gupta K. Cardiac catheterization in patients with end-stage liver disease: safety and outcomes. Catheter Cardiovasc Interv. 2010 Apr 15. [Epub ahead of print].

Selected Abstracts Presented at National Meetings

  • Sheldon S, Tadros P, Jones C, Rosamond T, Wiley M. Coronary Artery Dominance:  Correlation With False Positive Regional Myocardial Perfusion Abnormalities. Presented at the 2008 Midwestern Section of the American Federation for Medical Research Annual Meeting, April 24-25 2008, Chicago Illinois.
  • Pillarisetti J, Patel P, Duthuluru S, Patel A, Chen W, Genton R, Wiley M, Candipan R, Tadros P, Gupta K. Cardiac Catheterization in Patients with End-Stage Liver Disease: Safety and Outcomes. Presented at the Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Conference 2009, April 23-25 2009, Washington DC.
  • Maugans C, Grier B, Humera D, Jones C, Sheldon S, Vacek J, Wiley M. Correlation of Fluctuating Ozone Levels with Hospital and Emergency Department Admissions for Chest Pain or Acute Coronary Syndromes. Presented at the 2009 Combined Annual Meeting, Central Society for Clinical Research, Midwestern Section American Federation for Medical Research, April 23-24 2009, Chicago Illinois.
  • Pillarisetti J, Lakkireddy D, Tadros P, Sayana H, Goucher H, Duthuluru S, Patel A, Biria M, Vacek J, Berenbom L, Gupta K, Nath J, Wiley M. Interventional Cardiologists and Electrophysiologists Beware! - Your Job Can Impact the Gender of Your Offspring Too! Presented at the 2009 Heart Rhythm Society Annual Meeting, May 13-16 2009, Boston Massachusetts.
  • Franano FN, Bland KS, Ding BC, Wiley M, Vacek J, Smirnov I, Henry C. PRT-101 Can Effect Positive Remodeling of the Porcine Iliac Artery. Presented at the 20th Annual Transcatheter Cardiovascular Therapeutics Symposium 2008, October 12-17 2008, Washington DC.
  • Franano FN, Bland KS, Ding BC, Wiley M, Vacek J, Smirnov I, Henry C. Prt-201 is a locally-acting recombinant human type I elastase that safely and persistently dilates segments of blood vessels in animal models and can be used as a "biological stent". Invited Oral Presentation, 20th Annual Transcatheter Cardiovascular Therapeutics Symposium 2008, October 12-17 2008, Washington DC.
Last modified: Feb 24, 2012

Mark A. Wiley, MD, FACC, FSCAI

Contact

Mark A. Wiley, MD, FACC, FSCAI
Assistant Professor of Medicine - Cardiology

ID=x2811